Moderna reaffirms annual COVID vaccine sales forecast
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Nasdaq futures drop over 2% as AI buildout costs, Fed rate outlook weigh
- Nasdaq 100 set to shed over $1 trillion as tech selloff deepens; SpaceX slides
- Oil prices fall as investors focus on Hormuz flows after peace talks
- SpaceX slides, tech stocks dip — what’s moving markets
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Moderna (MRNA) 'remains comfortable' with Covid vaccine guidance range after Pfizer slashes forecast
October 16, 2023 2:29 PM EDTPharmaceutical company Moderna (NASDAQ: MRNA) released a short statement Monday, aiming to ease worries regarding sales of its Coivd vaccine.
The company's share price dropped Monday after larger rival Pfizer (NYSE: PFE) slashed its 2023 revenue projection by $9 billion late Friday.... More
